Annis Gardner Whiting Capital Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.2K Sell
72
-6
-8% -$1.63K ﹤0.01% 745
2025
Q4
$19.6K Sell
78
-19
-20% -$5.05K ﹤0.01% 660
2025
Q3
$27.8K Buy
97
+5
+5% +$1.34K 0.01% 560
2025
Q2
$24.2K Buy
92
+26
+39% +$6.33K 0.01% 534
2025
Q1
$15.4K Hold
66
0.01% 493
2024
Q4
$15.1K Hold
66
﹤0.01% 483
2024
Q3
$14.8K Hold
66
﹤0.01% 504
2024
Q2
$13.4K Sell
66
-6
-8% -$1.22K ﹤0.01% 640
2024
Q1
$15.7K Buy
72
+37
+106% +$8.15K 0.01% 605
2023
Q4
$7.96K Hold
35
﹤0.01% 498
2023
Q3
$7.04K Buy
+35
New +$7.38K ﹤0.01% 499

Other funds holding LH

Annis Gardner Whiting Capital Advisors's LH Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its Labcorp (LH) stake by 7.7% in Q1 2026, selling an estimated $1.63K and leaving 72 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #745.

Annis Gardner Whiting Capital Advisors first reported a position in LH in Q3 2023 and has held it in 11 quarters since. The position peaked at $27.8K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Annis Gardner Whiting Capital Advisors held 72 shares of Labcorp worth $19.2K as of Q1 2026.
  • Annis Gardner Whiting Capital Advisors sold 6 Labcorp shares in Q1 2026, an estimated $1.63K.
  • Labcorp made up ﹤0.01% of Annis Gardner Whiting Capital Advisors's portfolio in Q1 2026, its #745 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Labcorp in Q3 2023 and has held it in 11 quarters since.
  • Annis Gardner Whiting Capital Advisors's Labcorp position peaked at $27.8K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.